Literature DB >> 25168426

Involvement of EZH2, SUV39H1, G9a and associated molecules in pathogenesis of urethane induced mouse lung tumors: potential targets for cancer control.

Manuraj Pandey1, Satya Sahay1, Prakash Tiwari1, Daya S Upadhyay2, Sarwat Sultana3, Krishna P Gupta4.   

Abstract

In the present study, we showed the correlation of EZH2, SUV39H1 or G9a expression and histone modifications with the urethane induced mouse lung tumorigenesis in the presence or absence of antitumor agent, inositol hexaphosphate (IP6). Tumorigenesis and the molecular events involved therein were studied at 1, 4, 12 or 36 weeks after the exposure. There were no tumors at 1 or 4 weeks but tumors started appearing at 12 weeks and grew further till 36 weeks after urethane exposure. Among the molecular events, upregulation of EZH2 and SUV39H1 expressions appeared to be time dependent, but G9a expression was altered significantly only at later stages of 12 or 36 weeks. Alteration in miR-138 expression supports the upregulation of its target, EZH2. H3K9me2, H3K27me3 or H4K20me3 was found to be altered at 12 or 36 weeks. However, ChIP analysis of p16 and MLH1 promoters showed their binding with H3K9me2 and H3K27me3 which was maximum at 36 weeks. Thus, histone modification and their interactions with gene promoter resulted in the reduced expression of p16 and MLH1. IP6 prevented the incidence and the size of urethane induced lung tumors. IP6 also prevented the urethane induced alterations in EZH2, SUV39H1, G9a expressions and histone modifications. Our results suggest that the alterations in the histone modification pathways involving EZH2 and SUV39H1 expressions are among the early events in urethane induced mouse lung tumorigenesis and could be exploited for cancer control.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EZH2; G9a histone methylation; Inositol hexaphosphate; Lung cancer; SUV39H1; Urethane

Mesh:

Substances:

Year:  2014        PMID: 25168426     DOI: 10.1016/j.taap.2014.08.015

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  11 in total

Review 1.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

2.  Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.

Authors:  Justin M Drake; Evan O Paull; Nicholas A Graham; John K Lee; Bryan A Smith; Bjoern Titz; Tanya Stoyanova; Claire M Faltermeier; Vladislav Uzunangelov; Daniel E Carlin; Daniel Teo Fleming; Christopher K Wong; Yulia Newton; Sud Sudha; Ajay A Vashisht; Jiaoti Huang; James A Wohlschlegel; Thomas G Graeber; Owen N Witte; Joshua M Stuart
Journal:  Cell       Date:  2016-08-04       Impact factor: 41.582

Review 3.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 4.  A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.

Authors:  Craig L Parfett; Daniel Desaulniers
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

5.  Expression of epigenetic modifiers is not significantly altered by exposure to secondhand smoke.

Authors:  Stella Tommasi; Albert Zheng; Ahmad Besaratinia
Journal:  Lung Cancer       Date:  2015-10-27       Impact factor: 5.705

Review 6.  Environmentally induced epigenetic toxicity: potential public health concerns.

Authors:  Emma L Marczylo; Miriam N Jacobs; Timothy W Gant
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

7.  Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells.

Authors:  Yang Yang; Wei Yin; Fengying Wu; Jiang Fan
Journal:  Onco Targets Ther       Date:  2017-06-14       Impact factor: 4.147

8.  A regulatory circuitry comprising TP53, miR-29 family, and SETDB1 in non-small cell lung cancer.

Authors:  Bifeng Chen; Jingdong Wang; Jieling Wang; Huan Wang; Xiuli Gu; Liang Tang; Xianhong Feng
Journal:  Biosci Rep       Date:  2018-09-13       Impact factor: 3.840

9.  Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice.

Authors:  Qixue Wang; Lei Sun; Xiaoxiao Yang; Xingzhe Ma; Qi Li; Yuanli Chen; Ying Liu; Di Zhang; Xiaoju Li; Rong Xiang; Yuquan Wei; Jihong Han; Yajun Duan
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

10.  Onset of the lymphocytic infiltration and hyperplasia preceding the proliferation in F1 mouse lungs from the N-ethyl-N-nitrosourea exposed mothers: Prevention during the lactation period by inositol hexaphosphate.

Authors:  Satya Sahay; Prakash Tiwari; Krishna P Gupta
Journal:  Toxicol Rep       Date:  2015-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.